Short-term efficacy and safety of desvenlafaxine in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder
Kornstein, Susan G, Jiang, Qin, Reddy, Sujana, Musgnung, Jeff J, Guico-Pabia, Christine J
Published in The journal of clinical psychiatry (01.08.2010)
Published in The journal of clinical psychiatry (01.08.2010)
Get more information
Journal Article
Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study
Davidson, Jonathan, Rothbaum, Barbara O, Tucker, Phebe, Asnis, Gregory, Benattia, Isma, Musgnung, Jeff J
Published in Journal of clinical psychopharmacology (01.06.2006)
Published in Journal of clinical psychopharmacology (01.06.2006)
Get more information
Journal Article
Onset of activity and time to response on individual CAPS-SX17 items in patients treated for post-traumatic stress disorder with venlafaxine ER: a pooled analysis
Stein, Dan J., Pedersen, Ron, Rothbaum, Barbara O., Baldwin, David S., Ahmed, Saeeduddin, Musgnung, Jeff, Davidson, Jonathan
Published in The international journal of neuropsychopharmacology (01.02.2009)
Published in The international journal of neuropsychopharmacology (01.02.2009)
Get full text
Journal Article
A pooled analysis of gender and trauma-type effects on responsiveness to treatment of PTSD with venlafaxine extended release or placebo
Rothbaum, Barbara O, Davidson, Jonathan R T, Stein, Dan J, Pedersen, Ron, Musgnung, Jeff, Tian, Xiao Wei, Ahmed, Saeeduddin, Baldwin, David S
Published in The journal of clinical psychiatry (01.10.2008)
Published in The journal of clinical psychiatry (01.10.2008)
Get more information
Journal Article
Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor-Davidson Resilience Scale
Davidson, Jonathan, Baldwin, David S, Stein, Dan J, Pedersen, Ron, Ahmed, Saeed, Musgnung, Jeff, Benattia, Isma, Rothbaum, Barbara O
Published in International clinical psychopharmacology (01.09.2008)
Published in International clinical psychopharmacology (01.09.2008)
Get more information
Journal Article
Remission with venlafaxine extended release or selective serotonin reuptake inhibitors in depressed patients: a randomized, open-label study
Thase, Michael E, Ninan, Philip T, Musgnung, Jeff J, Trivedi, Madhukar H
Published in Primary care companion for CNS disorders (2011)
Published in Primary care companion for CNS disorders (2011)
Get full text
Journal Article
Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial
Davidson, Jonathan, Baldwin, David, Stein, Dan J, Kuper, Enrique, Benattia, Isma, Ahmed, Saeed, Pedersen, Ron, Musgnung, Jeff
Published in Archives of general psychiatry (01.10.2006)
Published in Archives of general psychiatry (01.10.2006)
Get more information
Journal Article
Abrupt discontinuation compared with a 1-week taper regimen in depressed outpatients treated for 24 weeks with desvenlafaxine 50 mg/d
Khan, Arif, Musgnung, Jeff, Ramey, Tanya, Messig, Michael, Buckley, Gina, Ninan, Philip T
Published in Journal of clinical psychopharmacology (01.06.2014)
Published in Journal of clinical psychopharmacology (01.06.2014)
Get more information
Journal Article
Efficacy and safety of desvenlafaxine 50 mg/d in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder
Clayton, Anita H, Kornstein, Susan G, Dunlop, Boadie W, Focht, Kristen, Musgnung, Jeff, Ramey, Tanya, Bao, Weihang, Ninan, Philip T
Published in The journal of clinical psychiatry (01.10.2013)
Published in The journal of clinical psychiatry (01.10.2013)
Get more information
Journal Article
A Meta-analysis of Factors Impacting Detection of Antidepressant Efficacy in Clinical Trials: The Importance of Academic Sites
DUNLOP, Boadie W, THASE, Michael E, WUN, Chuan-Chuan, FAYYAD, Rana, GUICO-PABIA, Christine J, MUSGNUNG, Jeff, NINAN, Philip T
Published in Neuropsychopharmacology (New York, N.Y.) (01.12.2012)
Published in Neuropsychopharmacology (New York, N.Y.) (01.12.2012)
Get full text
Journal Article
An evaluation of sexual functioning in employed outpatients with major depressive disorder treated with desvenlafaxine 50 mg or placebo
Clayton, Anita H, Reddy, Sujana, Focht, Kristen, Musgnung, Jeff, Fayyad, Rana
Published in Journal of sexual medicine (01.03.2013)
Published in Journal of sexual medicine (01.03.2013)
Get more information
Journal Article
Venlafaxine extended release in the short-term treatment of depressed and anxious primary care patients with multisomatoform disorder
Kroenke, Kurt, Messina, 3rd, Nicholas, Benattia, Isma, Graepel, Jay, Musgnung, Jeff
Published in The journal of clinical psychiatry (01.01.2006)
Published in The journal of clinical psychiatry (01.01.2006)
Get more information
Journal Article
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases
Keller, Martin B, Trivedi, Madhukar H, Thase, Michael E, Shelton, Richard C, Kornstein, Susan G, Nemeroff, Charles B, Friedman, Edward S, Gelenberg, Alan J, Kocsis, James H, Dunner, David L, Hirschfeld, Robert M A, Rothschild, Anthony J, Ferguson, James M, Schatzberg, Alan F, Zajecka, John M, Pedersen, Ronald D, Yan, Bing, Ahmed, Saeeduddin, Musgnung, Jeff, Ninan, Philip T
Published in The journal of clinical psychiatry (01.08.2007)
Published in The journal of clinical psychiatry (01.08.2007)
Get more information
Journal Article
Efficacy of desvenlafaxine 50 mg compared with placebo in patients with moderate or severe major depressive disorder: a pooled analysis of six randomized, double-blind, placebo-controlled studies
Papakostas, George I, Culpepper, Larry, Fayyad, Rana S, Musgnung, Jeff, Guico-Pabia, Christine J
Published in International clinical psychopharmacology (01.11.2013)
Published in International clinical psychopharmacology (01.11.2013)
Get more information
Journal Article
Incidence and Timing of Taper/Posttherapy-Emergent Adverse Events Following Discontinuation of Desvenlafaxine 50 mg/d in Patients With Major Depressive Disorder
Ninan, Philip T, Musgnung, Jeff, Messig, Michael, Buckley, Gina, Guico-Pabia, Christine J, Ramey, Tanya S
Published in Primary care companion for CNS disorders (2015)
Published in Primary care companion for CNS disorders (2015)
Get full text
Journal Article
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study
Kocsis, James H, Thase, Michael E, Trivedi, Madhukar H, Shelton, Richard C, Kornstein, Susan G, Nemeroff, Charles B, Friedman, Edward S, Gelenberg, Alan J, Dunner, David L, Hirschfeld, Robert M A, Rothschild, Anthony J, Ferguson, James M, Schatzberg, Alan F, Zajecka, John M, Pedersen, Ronald D, Yan, Bing, Ahmed, Saeed, Musgnung, Jeff, Ninan, Philip T, Keller, Martin B
Published in The journal of clinical psychiatry (01.07.2007)
Published in The journal of clinical psychiatry (01.07.2007)
Get more information
Journal Article
Clinical utility of desvenlafaxine 50 mg/d for treating MDD: a review of two randomized placebo-controlled trials for the practicing physician
Reddy, Sujana, Kane, Cecelia, Pitrosky, Bruno, Musgnung, Jeff, Ninan, Philip T, Guico-Pabia, Christine J
Published in Current medical research and opinion (01.01.2010)
Published in Current medical research and opinion (01.01.2010)
Get more information
Journal Article
Patient outcomes with education, drug therapy, and support: a study of venlafaxine ER-treated outpatients with major depressive disorder
Lobello, Kasia, Reddy, Sujana, Musgnung, Jeff, Pedersen, Ronald, Ninan, Philip T
Published in Psychopharmacology bulletin (01.01.2010)
Get more information
Published in Psychopharmacology bulletin (01.01.2010)
Journal Article